SWK Holdings Corporation is an asset management business based in the US. SWK Holdings Corporation shares (SWKH) are listed on the NASDAQ and all prices are listed in US Dollars. SWK Holdings Corporation employs 35 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $18.96 |
|---|---|
| 52-week range | $12.75 - $20.49 |
| 50-day moving average | $19.10 |
| 200-day moving average | $18.02 |
| Wall St. target price | $36.00 |
| PE ratio | 10.2006 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $1.89 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $18.96 from 2022-01-21
| 1 week (2022-01-14) | -1.86% |
|---|---|
| 1 month (2021-12-23) | -1.56% |
| 3 months (2021-10-22) | -2.17% |
| 6 months (2021-07-23) | 6.22% |
| 1 year (2021-01-22) | 35.91% |
|---|---|
| 2 years (2020-01-24) | 37.49% |
| 3 years (2019-01-24) | 83.19% |
| 5 years (2017-01-24) | 81.96% |
Valuing SWK Holdings Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of SWK Holdings Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
SWK Holdings Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, SWK Holdings Corporation shares trade at around 10x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
| Revenue TTM | $51.7 million |
|---|---|
| Operating margin TTM | 52.7% |
| Gross profit TTM | $32 million |
| Return on assets TTM | 9.09% |
| Return on equity TTM | 9.77% |
| Profit margin | 46.89% |
| Book value | $20.36 |
| Market capitalisation | $247.5 million |
TTM: trailing 12 months
We're not expecting SWK Holdings Corporation to pay a dividend over the next 12 months.
SWK Holdings Corporation's shares were split on a 1:10 basis on 6 October 2015. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your SWK Holdings Corporation shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for SWK Holdings Corporation shares which in turn could have impacted SWK Holdings Corporation's share price.
Over the last 12 months, SWK Holdings Corporation's shares have ranged in value from as little as $12.75 up to $20.49. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while SWK Holdings Corporation's is 0.2651. This would suggest that SWK Holdings Corporation's shares are less volatile than average (for this exchange).
SWK Holdings Corporation, a specialty finance company, focuses on the healthcare sector. The company operates in two segments, Finance Receivables and Pharmaceutical Development. It provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. The company, through its subsidiary, SWK Advisors LLC, offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. The company also engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Its product pipeline includes Ovarest, an oral leuprolide tablet to treat endometriosis; and Tobrate, an oral tobramycin tablet for the treatment of uncomplicated urinary tract infections. The company was formerly known as Kana Software, Inc.
Bitcoin breached the $40,000 price level and may plummet lower as Russia signals a potential ban.
Cardano’s first metaverse project is available to investors now — if you can find a piece of digital land on sale. Plots sold fast despite the project’s early stage limitations.
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Read our expert analysis on Vigorus and how the token will perform in the future.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.